M. Veillard

2.1k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

M. Veillard is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, M. Veillard has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 10 papers in Biomaterials and 4 papers in Molecular Biology. Recurrent topics in M. Veillard's work include Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Drug Solubulity and Delivery Systems (6 papers). M. Veillard is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Drug Solubulity and Delivery Systems (6 papers). M. Veillard collaborates with scholars based in France, United States and Austria. M. Veillard's co-authors include G. Spenlehauer, Didier Bazile, Jean‐Pierre Benoît, Patrick Couvreur, Mark A. Longer, Joseph R. Robinson, Jean–Louis Grossiord, Christine Vauthier, F. Puisieux and Denis Labarre and has published in prestigious journals such as Biomaterials, Langmuir and Journal of Controlled Release.

In The Last Decade

M. Veillard

19 papers receiving 1.6k citations

Hit Papers

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mon... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Veillard France 15 981 733 442 359 219 19 1.7k
Didier Bazile France 21 1.1k 1.2× 631 0.9× 615 1.4× 485 1.4× 258 1.2× 32 1.9k
Huguette Pinto‐Alphandary France 16 634 0.6× 548 0.7× 470 1.1× 271 0.8× 226 1.0× 19 1.6k
Hongkee Sah South Korea 18 847 0.9× 1.1k 1.6× 664 1.5× 454 1.3× 114 0.5× 60 2.2k
Florian T. Unger Germany 17 775 0.8× 333 0.5× 566 1.3× 260 0.7× 300 1.4× 30 1.7k
Gro Smistad Norway 25 411 0.4× 555 0.8× 500 1.1× 235 0.7× 183 0.8× 60 1.7k
Sema Çalış Türkiye 26 734 0.7× 676 0.9× 487 1.1× 362 1.0× 153 0.7× 54 1.9k
Mats Reslow Sweden 13 558 0.6× 530 0.7× 621 1.4× 368 1.0× 133 0.6× 18 1.7k
Vincent Pourcelle Belgium 17 771 0.8× 496 0.7× 769 1.7× 360 1.0× 118 0.5× 24 1.6k
Hiromitsu Yamamoto Japan 23 715 0.7× 1.4k 1.9× 735 1.7× 227 0.6× 172 0.8× 47 2.4k
Donald E. Chickering United States 13 342 0.3× 525 0.7× 313 0.7× 326 0.9× 88 0.4× 15 1.4k

Countries citing papers authored by M. Veillard

Since Specialization
Citations

This map shows the geographic impact of M. Veillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Veillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Veillard more than expected).

Fields of papers citing papers by M. Veillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Veillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Veillard. The network helps show where M. Veillard may publish in the future.

Co-authorship network of co-authors of M. Veillard

This figure shows the co-authorship network connecting the top 25 collaborators of M. Veillard. A scholar is included among the top collaborators of M. Veillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Veillard. M. Veillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vauthier, Christine, et al.. (2003). The Design of Nanoparticles Obtained by Solvent Evaporation:  A Comprehensive Study. Langmuir. 19(22). 9504–9510. 174 indexed citations
2.
Landry, France, et al.. (1998). Peroral Administration of14C-Poly(D,L-Lactic Acid) Nanoparticles Coated with Human Serum Albumin or Polyvinyl Alcohol to Guinea Pigs. Journal of drug targeting. 6(4). 293–307. 21 indexed citations
3.
Landry, France, Didier Bazile, G. Spenlehauer, M. Veillard, & J. Kreuter. (1997). Release of the fluorescent marker Prodan® from poly(D,L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII). Journal of Controlled Release. 44(2-3). 227–236. 31 indexed citations
4.
Bazile, Didier, et al.. (1996). Encapsulation of oligonucleotides in stealth Me.PEG-PLA50nanoparticles by complexation with structured oligopeptides. Drug Delivery. 3(3). 187–195. 24 indexed citations
5.
Bazile, Didier, et al.. (1996). Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials. 17(16). 1575–1581. 158 indexed citations
6.
Bazile, Didier, et al.. (1995). Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System. Journal of Pharmaceutical Sciences. 84(4). 493–498. 510 indexed citations breakdown →
7.
Spenlehauer, G., et al.. (1995). Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. Journal of Controlled Release. 36(1-2). 49–61. 158 indexed citations
8.
Bazile, Didier, et al.. (1993). Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. Journal of Biomedical Materials Research. 27(8). 1019–1028. 71 indexed citations
9.
Ropert, Catherine, et al.. (1993). Fate of 14C radiolabeled poly(dl-lactic acid) nanoparticles following oral administration to rats. Colloids and Surfaces B Biointerfaces. 1(4). 233–239. 10 indexed citations
10.
11.
Husson, Isabelle, Bernard Leclerc, G. Spenlehauer, et al.. (1992). Influence of size polydispersity on drug release from coated pellets. International Journal of Pharmaceutics. 86(2-3). 113–121. 10 indexed citations
12.
Maitani, Yoshie, et al.. (1992). Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch. International Journal of Pharmaceutics. 84(2). 117–128. 52 indexed citations
13.
Husson, Isabelle, Bernard Leclerc, G. Spenlehauer, M. Veillard, & Guy Couarraze. (1991). Modelling of drug release from pellets coated with an insoluble polymeric membrane. Journal of Controlled Release. 17(2). 163–173. 19 indexed citations
14.
Tucker, Ian G., Martin E. Dowty, M. Veillard, Mark A. Longer, & Joseph R. Robinson. (1989). Reversed-Phase High-Performance Liquid Chromatographic Analysis of Oligoglycines (One to Six Amino Acid Residues). Pharmaceutical Research. 6(1). 100–102. 10 indexed citations
15.
Spenlehauer, G., Michel Vert, Jean‐Pierre Benoît, F. Chabot, & M. Veillard. (1988). Biodegradable cisplatiim microspheres prepared by the solvent evaporation method: Morphology and release characteristics. Journal of Controlled Release. 7(3). 217–229. 103 indexed citations
16.
Robinson, Joseph R., Mark A. Longer, & M. Veillard. (1987). Bioadhesive Polymers for Controlled Drug Delivery. Annals of the New York Academy of Sciences. 507(1). 307–314. 36 indexed citations
17.
Veillard, M., Mark A. Longer, Thomas W. Martens, & Joseph R. Robinson. (1987). Preliminary studies of oral mucosal delivery of peptide drugs. Journal of Controlled Release. 6(1). 123–131. 63 indexed citations
18.
Spenlehauer, G., M. Veillard, & Jean‐Pierre Benoît. (1986). Formation and Characterization of Cisplatin Loaded Poly(d,l-Lactide) Microspheres for Chemoembolization. Journal of Pharmaceutical Sciences. 75(8). 750–755. 117 indexed citations
19.
Veillard, M., et al.. (1979). Moisture Transfer Tests in Blister Package Testing. Drug Development and Industrial Pharmacy. 5(3). 227–244. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026